Free Trial

Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lowered by Artemis Investment Management LLP

Intuitive Surgical logo with Medical background

Artemis Investment Management LLP decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 42.1% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 53,789 shares of the medical equipment provider's stock after selling 39,188 shares during the period. Artemis Investment Management LLP's holdings in Intuitive Surgical were worth $28,076,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of ISRG. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $36,000. Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the third quarter valued at about $38,000. Finally, DT Investment Partners LLC raised its holdings in shares of Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock worth $40,000 after purchasing an additional 36 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Activity

In related news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the business's stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company's stock, valued at $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a research report on Wednesday, December 11th. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $554.17.

Check Out Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Price Performance

ISRG traded up $8.56 during trading hours on Monday, hitting $592.64. 2,630,118 shares of the stock were exchanged, compared to its average volume of 1,158,623. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68. The stock has a 50-day simple moving average of $540.66 and a 200-day simple moving average of $499.64. The stock has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines